These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7411552)

  • 21. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation.
    Pifl C; Hornykiewicz O
    Eur J Pharmacol; 1988 Jan; 146(1):189-91. PubMed ID: 3258244
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.
    Berger JG; Chang WK; Clader JW; Hou D; Chipkin RE; McPhail AT
    J Med Chem; 1989 Aug; 32(8):1913-21. PubMed ID: 2666667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal.
    Ongini E; Caporali MG; Massotti M
    Life Sci; 1985 Dec; 37(24):2327-33. PubMed ID: 3877855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemical basis for the blockade of the D-1 dopamine receptor by SCH 23390.
    Itoh Y; Beaulieu M; Kebabian JW
    Eur J Pharmacol; 1984 Apr; 100(1):119-22. PubMed ID: 6144550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and renal vasodilator activity of 2-chlorodopamine and N-substituted derivatives.
    McCarthy JR; McCowan J; Zimmerman MB; Wenger MA; Emmert LW
    J Med Chem; 1986 Sep; 29(9):1586-90. PubMed ID: 3528490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-1 dopamine receptors and arousal.
    Ongini E
    Adv Exp Med Biol; 1988; 235():169-78. PubMed ID: 2976250
    [No Abstract]   [Full Text] [Related]  

  • 27. Induction of oral dyskinesias in naive rats by D1 stimulation.
    Rosengarten H; Schweitzer JW; Friedhoff AJ
    Life Sci; 1983 Dec; 33(25):2479-82. PubMed ID: 6227782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Regulation of neural transmission in the mouse vas deferens by 2 subtypes of dopaminergic receptors].
    Mitolo-Chieppa D; Carratù MR; De Serio A; Ferrari E; Conte-Camerino D; Damiani M
    Boll Soc Ital Biol Sper; 1988 Aug; 64(8):763-8. PubMed ID: 2850821
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of specific D-1 and D-2 dopamine agonists (LY141865 and SKF-38393) and pergolide on urinary output of rats.
    Leander JD
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):290-5. PubMed ID: 2962555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Manipulation of dopamine receptors alters hypoxic pulmonary vasoconstriction in isolated perfused rat lungs.
    Polak MJ; Kennedy LA; Drummond WH
    Life Sci; 1992; 51(17):1317-23. PubMed ID: 1357520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.
    Stoof JC; Kebabian JW
    Nature; 1981 Nov; 294(5839):366-8. PubMed ID: 6273735
    [No Abstract]   [Full Text] [Related]  

  • 33. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.
    Imperato A; Mulas A; Di Chiara G
    Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of plasma prolactin concentrations by intravenous SCH 23390 and SKF 38393 in conscious rats.
    Tanimoto K; Tamminga CA; Chase TN
    Eur J Pharmacol; 1987 Dec; 144(2):147-51. PubMed ID: 3325296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.
    Braun AR; Chase TN
    Eur J Pharmacol; 1986 Nov; 131(2-3):301-6. PubMed ID: 3493161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Functional interaction of dopamine receptors and chronic treatment with dopamine-antagonists].
    Barone P; Tucci I; Parashos SA
    Ann Ist Super Sanita; 1988; 24(4):547-50. PubMed ID: 3265291
    [No Abstract]   [Full Text] [Related]  

  • 37. Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors.
    Andén NE; Grabowska-Andén M
    Acta Physiol Scand; 1987 Sep; 131(1):157-8. PubMed ID: 2890261
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peripheral dopaminergic receptor agonists as potential drugs in diseases of the circulatory system].
    Kostowski W
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1448-51. PubMed ID: 2870482
    [No Abstract]   [Full Text] [Related]  

  • 40. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats.
    Chen CJ; Apparsundaram S; Lokhandwala MF
    J Pharmacol Exp Ther; 1991 Feb; 256(2):486-91. PubMed ID: 1671595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.